RUSHNET, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0003 USD | +20.00% |
|
0.00% | +50.00% |
| 07/03 | Rushnet Partners with Royal Caridea LLC Through an Exclusive Licensing Agreement to Revolutionize Sustainable Aquaculture | CI |
| 04/03 | RushNet, Inc Announces Executive Changes | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2020 | 4.39M 366M | Sales 2021 | 5.9M 492M | Capitalization | 4.5M 375M |
|---|---|---|---|---|---|
| Net income 2020 | - 0 | Net income 2021 | - 0 | EV / Sales 2020 | 2.75 x |
| Net Debt 2020 | 5.87M 490M | Net Debt 2021 | 5.93M 495M | EV / Sales 2021 | 1.77 x |
| P/E ratio 2020 |
13.3
x | P/E ratio 2021 |
55
x | Employees | - |
| Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +20.00% | ||
| 1 month | -25.00% | ||
| 3 months | -25.00% | ||
| 6 months | +200.00% | ||
| Current year | +50.00% |
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.02
5 years
0.000.02
10 years
0.000.02
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | 43 | 02/21/02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 0.0003 | +20.00% | 855,574 |
| 02/24/02 | 0.00025 | -16.67% | 233,523 |
| 01/24/01 | 0.0003 | 0.00% | 30,000 |
| 30/24/30 | 0.0003 | 0.00% | 1,960,000 |
| 29/24/29 | 0.0003 | +20.00% | 2,465,000 |
Delayed Quote OTC Markets, May 04, 2024 at 01:23 am IST
More quotes
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.
Sector
Business Support Services
| 1st Jan change | Capi. | |
|---|---|---|
| +50.00% | 2.63M | |
| +8.03% | 7.55B | |
| -31.57% | 3.39B | |
| +10.69% | 2.78B | |
| -1.88% | 1.58B | |
| -9.51% | 1.08B | |
| +21.91% | 841M | |
| -7.02% | 740M | |
| -2.77% | 611M | |
| -20.72% | 526M |
- Stock Market
- Equities
- RSHN Stock